Quel est le prix pour MYUNGMOON Pharm co.,Ltd (017180)

Le prix pour MYUNGMOON Pharm co.,Ltd (017180) est $0.84293068

Quelle est la capitalisation boursière pour MYUNGMOON Pharm co.,Ltd (017180)

La capitalisation boursière pour MYUNGMOON Pharm co.,Ltd (017180) est $28.18M

MYUNGMOON Pharm co.,Ltd (017180) Prix et Capitalisation Boursière

MYUNGMOON Pharm Co., Ltd. operates as a pharmaceutical enterprise, comprehensively handling the research, development, production, distribution, and commercialization of medicinal products. Its business activities extend across South Korea and into global markets. The company offers an extensive array of prescription drugs, addressing a broad spectrum of medical conditions. This range includes treatments for musculoskeletal issues like osteoarthritis, inflammation, rheumatoid arthritis, and muscle relaxation, alongside anti-infectives (antibiotics and antifungals), respiratory aids, and gastrointestinal therapeutics. Cardiovascular health is targeted with circulation agents, anti-hypertensive drugs, and antidiabetic medications. Furthermore, their specialized pharmacotherapy solutions cover narcotics, anesthetics, central nervous system agents, female hormone products, osteoporosis treatments, urogenital medications, adrenocortical hormones, oncology drugs, dermal fillers, and anti-obesity agents. Beyond prescription items, MYUNGMOON Pharm also supplies a diverse selection of over-the-counter (OTC) remedies. These encompass medications for nausea, genitourinary concerns, gum disease, liver support, parasitic infections, constipation, oral ailments, diarrhea, and general digestive health. The OTC portfolio further includes cold and flu treatments, calcium supplements, nasal sprays, multi-vitamins, eye nutrition products, eye drops, blood circulation enhancers, and topical preparations such as external skin treatments and localized pain relievers. In addition to its pharmaceutical lines, the firm markets health supplements, quasi-pharmaceuticals, and blended juice beverages. Established in 1983, MYUNGMOON Pharm Co., Ltd. maintains its primary corporate office in Seoul, South Korea.

Prix pour 017180	L’actif B	La capitalisation boursière de B	Résultats
$158,564 $28.18M	NVDA	$5.301T	+18,810,889.37%
$138,612 $28.18M	AAPL	$4.634T	+16,443,932.10%
$123,928 $28.18M	GOOG	$4.143T	+14,701,938.95%
$107,368 $28.18M	MSFT	$3.589T	+12,737,371.11%
$85,459.22 $28.18M	AMZN	$2.857T	+10,138,245.37%

Prix pour 017180

L’actif B

La capitalisation boursière de B

Résultats

$158,564 $28.18M